Stay updated on Trastuzumab Deruxtecan Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Deruxtecan Clinical Trial page.

Latest updates to the Trastuzumab Deruxtecan Clinical Trial page
- Check2 days agoChange DetectedThe Locations section was updated with numerous new entries across multiple countries and regions. Several previously listed city-level locations, such as Buenos Aires F.D., Córdoba Province, Tucumán Province, Cautín, and Santiago Metropolitan, were removed.SummaryDifference0.9%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision history shows the addition of Revision: v3.3.2 and removal of Revision: v3.3.1; no study details or functional elements were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedMinor wording changes clarify how PubMed publications are shown and note the page revision version (v3.3.1 vs v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded a new study site in Tainan, Taiwan (70457) and updated location naming and timing fields (Last Update Posted and related dates); a government funding notice was removed.SummaryDifference0.3%

- Check52 days agoChange DetectedThe Publications section now references the DESTINY-Gastric04 trial publication, and there are minor layout updates on the page. Otherwise, core trial details such as enrollment, locations, eligibility criteria, and the primary/secondary outcomes remain unchanged.SummaryDifference0.2%

- Check81 days agoChange DetectedUpdated the page version from v3.0.2 to v3.2.0; no other content changes detected.SummaryDifference0.0%

Stay in the know with updates to Trastuzumab Deruxtecan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan Clinical Trial page.